Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer

被引:291
|
作者
Yao, Dianbo [1 ]
Dong, Ming [2 ]
Dai, Chaoliu [1 ]
Wu, Shuodong [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang 110004, Liaoning, Peoples R China
[2] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Shenyang 110004, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
ulcerative colitis; colitis-associated cancer; inflammation; TLR4; NF-kappa B; macrophages; TNF-alpha; IL-6; NF-KAPPA-B; TOLL-LIKE RECEPTOR-4; INTESTINAL EPITHELIAL-CELLS; DEXTRAN SODIUM-SULFATE; MACROPHAGE POLARIZATION; SIGNALING PATHWAYS; COLORECTAL-CANCER; GUT MICROBIOTA; BOWEL-DISEASE; TNF-ALPHA;
D O I
10.1093/ibd/izz149
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dysregulated inflammatory responses play a pivotal role in the initiation, development, and progression of tumors, as demonstrated by the association between ulcerative colitis and the increased risk of colon carcinoma. In this review, the underlying mechanisms for the initiation and development of ulcerative colitis and colitis-associated cancer are described, mainly focusing on the inflammation and inflammatory cytokine. Disruption of the intestinal mucosal barrier and bacterial invasion resulted in intestinal inflammation; and further TLR4/NF-kappa B stimulation in intestinal epithelial cells, inflammatory cell infiltration, and inflammatory cytokine release all confer survival advantages to or promote abnormal proliferation in susceptible cells. Importantly, the respective roles of TLR4/NF-kappa B, TNF-alpha, and IL-6 in intestinal epithelial cells and inflammatory cells are summarized in detail. A thorough understanding of these molecular mechanisms may help researchers and clinicians to explore novel approaches for the prevention and treatment of colitis-associated cancer.
引用
收藏
页码:1595 / 1602
页数:8
相关论文
共 50 条
  • [21] Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy
    Zhu, Cuipeng
    Li, Kaiqi
    Peng, Xiao-Xu
    Yao, Tong-Jia
    Wang, Zi-Yu
    Hu, Ping
    Cai, Demin
    Liu, Hao-Yu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies
    Fantini, Massimo Claudio
    Guadagni, Ilaria
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (05) : 558 - 565
  • [23] Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression
    Servais, L.
    Wera, O.
    Epoh, J. Dibato
    Delierneux, C.
    Bouznad, N.
    Rahmouni, S.
    Mazzucchelli, G.
    Baiwir, D.
    Delvenne, P.
    Lancellotti, P.
    Oury, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (04) : 762 - 777
  • [24] Status of colitis-associated cancer in ulcerative colitis
    Tetsushi Kinugasa
    Yoshito Akagi
    World Journal of Gastrointestinal Oncology, 2016, (04) : 351 - 357
  • [25] Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis
    Steiner, Stefanie
    Daniel, Carolin
    Fischer, Anika
    Atreya, Imke
    Hirschmann, Simon
    Waldner, Maximilian
    Neumann, Helmut
    Neurath, Markus
    Atreya, Raja
    Weigmann, Benno
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2015, 63 (01) : 53 - 63
  • [26] Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
    Yamamoto-Furusho, Jesus K.
    Gutierrez-Herrera, Fausto D.
    CELLS, 2025, 14 (03)
  • [27] Role of Different Inflammatory and Tumor Biomarkers in the Development of Ulcerative Colitis-associated Carcinogenesis
    Talero, E.
    Sanchez-Fidalgo, S.
    Villegas, I.
    Alarcon-de-la-Lastra, Catalina
    Illanes, M.
    Motilva, V.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (03) : 696 - 710
  • [28] Downregulation of trefoil factor-3 expression in the rectum is associated with the development of ulcerative colitis-associated cancer
    Kondo, Satoru
    Araki, Toshimitsu
    Toiyama, Yuji
    Tanaka, Koji
    Kawamura, Mikio
    Okugawa, Yoshinaga
    Okita, Yoshiki
    Saigusa, Susumu
    Inoue, Yasuhiro
    Uchida, Keiichi
    Mohri, Yasuhiko
    Kusunoki, Masato
    ONCOLOGY LETTERS, 2018, 16 (03) : 3658 - 3664
  • [29] Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis
    Han, Hongwei
    Sun, Wenxue
    Feng, Lu
    Wen, Zhongling
    Yang, Minkai
    Ma, Yingying
    Fu, Jiangyan
    Ma, Xiaopeng
    Xu, Xinhong
    Wang, Zhaoyue
    Yin, Tongming
    Wang, Xiao-Ming
    Lu, Gui-Hua
    Qi, Jin-Liang
    Lin, Hongyan
    Yang, Yonghua
    PEERJ, 2021, 9
  • [30] The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model
    Liu, Yunxin
    Fang, Xianjun
    Yuan, Jie
    Sun, Zongxing
    Li, Chuanhua
    Li, Rong
    Li, Li
    Zhu, Chao
    Wan, Rong
    Guo, Rui
    Jin, Lai
    Li, Shengnan
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : 639 - 651